PRKAA1 and diabetes mellitus: Metformin (MTF), commonly used as an anti-diabetic drug and AMPK activator, restored both AMPK phosphorylation levels and podocyte sensitivity to insulin under conditions that mimicked diabetes [29], suggesting the key role of AMPK in the regulation of glucose uptake in podocytes.